Vertex Pharmaceuticals could soon capture $10 billion in sales of non-opioid painkillers, an analyst said Friday as Vertex stock jumped. Yahoo Finance host Josh Lipton breaks down the day's top ...

Vertex Pharmaceuticals Incorporated (VRTX) stock price is 461.68 and Vertex Pharmaceuticals Incorporated (VRTX) 10-day simple moving average is 438.34. Vertex Pharmaceuticals Incorporated (VRTX ...

After hours: 7:59:16 p.m. EST ...

After hours: January 31 at 7:56:30 PM EST ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.

Guj Terce Labs Standalone June 2024 Net Sales at Rs 11.89 crore, up 10.93% Y-o-Y Aug 13 2024 01:37 PM Guj Terce Labs Standalone March 2024 Net Sales at Rs 12.21 crore, down 5.29% Y-o-Y Jun 07 2024 ...

Ambalal Sarabha Consolidated June 2024 Net Sales at Rs 40.70 crore, up 12.73% Y-o-Y Aug 21 2024 01:17 PM Ambalal Sarabha Standalone June 2024 Net Sales at Rs 1.14 crore, down 32.95% Y-o-Y Aug 13 ...

Vertex Pharmaceuticals (NASDAQ: VRTX) just snagged its second U.S. Food and Drug Administration (FDA) approval in only 41 ...

The company announced that the Food and Drug Administration (FDA) has approved Journavx, a twice-daily pill that it described as a "highly selective NaV1.8 pain signal inhibitor for the treatment of ...

Vertex Pharmaceuticals (NASDAQ:VRTX), a leading biotechnology company known for its cystic fibrosis (CF) treatments, is at a critical juncture as it seeks to diversify its portfolio and maintain its ...

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF ...

Analyst Andrew Fein of H.C. Wainwright maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report), boosting the price target to ...